Luc Mortelmans

Repetitive ¹⁸F‐fluorodeoxyglucose positron emission tomography in giant cell arteritis: A prospective study of 35 patients

Daniël Blockmans, L. De Ceuninck, Steven Vanderschueren et al. · Arthritis Care & Research · 2006 · 608 citations

Utility of Positron Emission Tomography for the Staging of Patients With Potentially Operable Esophageal Carcinoma

Patrick Flamen, Antoon Lerut, Eric Van Cutsem et al. · Journal of Clinical Oncology · 2000 · 571 citations

18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)

Sigrid Stroobants, J. Goeminne, M. Seegers et al. · European Journal of Cancer · 2003 · 526 citations

Oncologic Imaging, Medical Imaging, Imatinib Mesylate +10

Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism

Julián Aragonés, Martin Schneider, Katie Van Geyte et al. · Nature Genetics · 2008 · 475 citations · Full text

Biochemistry, Redox Regulator, Physiology +9

Prognostic Value of Positron Emission Tomography (PET) With Fluorine-18 Fluorodeoxyglucose ([¹⁸F]FDG) After First-Line Chemotherapy in Non-Hodgkin’s Lymphoma: Is [¹⁸F]FDG-PET a Valid Alternative to Conventional Diagnostic Methods?

Karoline Spaepen, Sigrid Stroobants, Patrick Dupont et al. · Journal of Clinical Oncology · 2001 · 466 citations